Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q4 2024 Earnings Call Transcript

Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q4 2024 Earnings Call Transcript February 27, 2025

Lisata Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.55, expectations were $-0.76.

Operator: Welcome to the Lisata Therapeutics’ Full Year 2024 Financial Results and Business Update Conference Call. Currently, all participants are in a listen-only mode. Following management’s prepared remarks, we will hold a Q&A session. [Operator Instructions]. As a reminder, this call is being...